1.
Ueda Y, Ishii H, Kitano T, Shindo M, Miyazawa H, Ito K, Hirai K, Kaku Y, Mori H, Hoshino T, Ookawara S, Kakei M, Tabei K, Morishita Y. Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers. dti [Internet]. 2016 Sep. 11 [cited 2024 Jul. 22];10(1). Available from: https://journals.aboutscience.eu/index.php/dti/article/view/1422